News
The estate of the singer, one of the three in Peter, Paul and Mary, is selling his Upper West Side apartment, “a hub of music ...
FDA approved Imfinzi with gemcitabine and cisplatin for muscle-invasive bladder cancer, based on NIAGARA trial results showing improved survival outcomes. The regimen integrates immunotherapy in pre- ...
OSLO, Norway, April 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces four abstract presentations at the AUA 2025, highlighting the benefits of Blue Light ...
Aidixi plus BCG showed strong early efficacy and manageable safety in patients with high-risk, HER2-expressing non–muscle-invasive bladder cancer. Aidixi (disitamab vedotin), an antibody-drug ...
The Phase 3 BOND-003 Cohort C study is in patients with high-risk non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette Guerin (BCG) treatment with carcinoma in situ (CIS ...
It separates the bladder from other body organs, such as the prostate and kidneys. Doctors describe your bladder cancer based on how far it has spread through these layers. You can have: non muscle ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
A 50-year-old UK father, mistook signs of bladder cancer for a UTI and kept drinking cranberry juice to treat the disease. A UK man revealed that after dismissing signs of an infection thinking it ...
A groundbreaking targeted treatment for the most common type of bladder cancer has been approved for use by the NHS, offering new hope to hundreds of patients. The National Institute of Health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results